1 BTC
=
- USD
Cyclerion Therapeutics, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Cyclerion Therapeutics, Inc. Common Stock
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Statistics
Trading Metrics
How to Buy CYCN
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy CYCN
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesHalper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern Soleno Therapeutics' sale to Neurocrine Biosciences, Forian's sale to a consortium led by its CEO, McCormick & Company's merger with Unilever's Foods business, and Cyclerion Therapeutics' merger with Korsana Biosciences. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.
– Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment –
CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that Cyclerion has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2), and that Cyclerion is in compliance with all applicable listing standards.
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. The Singing Machine Company, Inc. (NASDAQ: MICS) surged 73% to $1.81 after the company announced termination of its at-the-market equity program. Applied Digital Corporation (NASDAQ: APLD) gained 44.6% to $4.94 after the company announced that its recently launched AI Cloud Service has secured its first major AI customer with an agreement worth up to $180 million over a 24-month period. OncoSec Medical Incorporated (NASDAQ: ONCS) jumped 30% to $1.08. OncoSec said Type C meeting with the FDA was held on May 15. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) gained 27.6% to $4.88. Cyclerion reported a 1-for-20 reverse stock split, effective 5 p.m. on May 15. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) jumped 24.4% to $4.18 after the company announced the FDA cleared its Investigational New Drug application to proceed with a clinical trial of its lead product candidate, PH-762. Blue Apron Holdings, Inc. (NYSE: APRN) jumped 25% to $0.5726. Blue Apron announced plans to shift to an asset-light model through the transfer of operational infrastructure to FreshRealm. VivoPower International PLC (NASDAQ: VVPR) shares gained 21.3% to $0.5631 after the company announced a definitive distribution agreement to distribute EV fleet charging solutions. Navitas Semiconductor Corporation (NASDAQ: NVTS) jumped 18.8% to $7.89 after the company reported better-than-expected Q1 financial results. Atlas Lithium Corporation (NASDAQ: ATLX) shares gained 18% to $22.39. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 17.8% to $4.82 after posting a profit for the first quarter. Troika Media Group, Inc. (NASDAQ: TRKA) jumped 17.7% to $0.2328 after the company reported revenue of $59.0 million and adjusted EBITDA of $1.5 million for the three months ended March 31, 2023. ASP Isotopes Inc. (NASDAQ: ASPI) shares gained 16.3% to $0.51 after declining around 7% on Monday. Troika Media Group, Inc. (NASDAQ: TRKA) shares rose 16.3% to $0.2302 after the company reported a rise in third-quarter sales. Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) gained 15.8% to $10.09. Top KingWin Ltd (NASDAQ: TCJH) gained 15% to $7.34. Nanobiotix S.A. (NASDAQ: NBTX) rose 13.2% to $5.31. Nanobiotix recently announced it is entering into final contract negotiations after agreement to a non-binding term ...
CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (the “Company”, “Cyclerion Therapeutics”, “Cyclerion”) (Nasdaq: CYCN) announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, effective as of 5:00 p.m. Eastern Time on May 15, 2023. The reverse stock split was approved by the Company’s stockholders at its annual meeting of stockholders held on May 15, 2023, with the final ratio determined by the Company’s board of directors.